Women can breathe sigh of relief when using vaginal estrogen to treat menopause symptoms

October 11, 2017

News flash... hot flashes aren't the only bothersome symptom of the menopause transition. Many postmenopausal women also experience sexual dysfunction and urinary problems that don't require estrogen pills but, rather, can be alleviated by vaginally administered estrogen. A new study shows that, despite previous misperceptions, this treatment option is not only effective, but also safe. The study results will be presented during The North American Menopause Society (NAMS) Annual Meeting in Philadelphia, October 11-14.

Vaginal estrogen in the form of a cream or suppository is highly effective in managing an array of sexual and collectively referred to as the genitourinary syndrome of menopause. Despite its proven effectiveness, the use of vaginal estrogen has been restricted by concerns of women and their healthcare providers regarding its potential link to such serious health issues as , breast cancer, stroke, and others. Examination of the data from the Women's Health Initiative (WHI) Observational Study of more than 45,000 participants showed, however, that the use of vaginal estrogen does not significantly increase the risk of or cancer, including breast, colorectal, and endometrial cancer. Nor is it related to an elevated risk of such other concerns as stroke, pulmonary embolism, hip fracture, or death.

"These results should help reassure women regarding the safety of vaginal estrogen," says Dr. Carolyn Crandall, lead author of the study from the University of California in Los Angeles.

"Studies like these are so valuable to help dispel misperceptions that keep women from getting the relief they seek," says Dr. JoAnn Pinkerton, NAMS executive director. "Women and their need to be armed with the latest facts so they can make informed decisions regarding their treatment options."

Drs. Crandall and Pinkerton are available for interviews before the presentation at the Annual Meeting.

Explore further: For post-menopausal women, vaginal estrogens do not raise risk of cancer, other diseases

Related Stories

For post-menopausal women, vaginal estrogens do not raise risk of cancer, other diseases

August 16, 2017
Women who have gone through menopause and who have been using a vaginal form of estrogen therapy do not have a higher risk of cardiovascular disease and cancer than women who have not been using any type of estrogen.

Painful sex and bladder problems take toll on women's libido during menopause

October 11, 2017
As women age, sexual activity typically declines. But that doesn't necessarily mean they are no longer interested in sex. The problem for many is physical. A new study demonstrates the impact on sexual activity of postmenopausal ...

How serious is postmenopausal bleeding?

October 11, 2017
If you're postmenopausal, you shouldn't be bleeding. The very definition of menopause is having gone more than 12 months without a period. So if you're still bleeding, something is wrong. Determining the seriousness of the ...

Hormone therapy may benefit migraine sufferers without increased risk of heart disease

October 11, 2017
Migraine headaches are common among women, but due to various health risks can be challenging to treat in the elderly. While hormone therapy is effective in relieving many menopause symptoms, its safe use in women with migraines ...

Transdermal estradiol shows promise in treating and preventing perimenopausal depression

October 11, 2017
Did you know you're two-to-four-times more likely to suffer from depression during the menopause transition? A new study suggests that transdermal estradiol could be the key to not only treating existing perimenopausal depression, ...

Once a lesbian always a lesbian, right? Or not?

October 11, 2017
Are people's sexual attractions likely to change as they age? That's the question at the core of an ongoing debate as to whether or not sexuality remains stable throughout a person's life. An upcoming presentation at The ...

Recommended for you

New insights into controversial diagnosis of adolescent chronic fatigue

October 23, 2017
Crucial new research could provide some clarity around the controversy surrounding the diagnosis and treatment of chronic fatigue syndrome (CFS) in adolescents. The research by the Murdoch Children's Research Institute published ...

Do boys really have a testosterone spurt at age four?

October 23, 2017
The idea that four-year-old boys have a spurt of testosterone is often used to explain challenging behaviour at this age.

New prevention exercise programme to reduce rugby injuries

October 23, 2017
A new dynamic 20-minute exercise programme, performed by rugby players before training and pre-match, could dramatically reduce injuries in the sport according to a benchmark study published today (Sunday 22 October).

Our laws don't do enough to protect our health data

October 23, 2017
Have you ever wondered why your computer often shows you ads that seem tailor-made for your interests? The answer is big data. By combing through extremely large datasets, analysts can reveal patterns in your behavior.

Expert: Be concerned about how apps collect, share health data

October 20, 2017
As of 2016 there were more than 165,000 health and wellness apps available though the Apple App Store alone. According to Rice University medical media expert Kirsten Ostherr, the Food and Drug Administration (FDA) regulates ...

Three million Americans carry loaded handguns daily, study finds

October 19, 2017
An estimated 3 million adult American handgun owners carry a firearm loaded and on their person on a daily basis, and 9 million do so on a monthly basis, new research indicates. The vast majority cited protection as their ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.